 In addition, the Amendment required drug advertising to disclose accurate information about side effects and efficacy of treatments.Finally, cheap generic drugs could no longer be marketed as expensive drugs under new trade names as new "breakthrough" medications.The law was signed by President John F. Kennedy on October 10, 1962.